Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|November 14, 2019
Scientific rationale underpinning the development of biosimilar rituximab in hematological cancers and inflammatory diseasesWojciech Jurczak, Stanley Cohen, Timothy M Illidge, et al.
Health Policy OPEN|August 1, 2026
Reframing the value of reserve antibiotics: how ultra-orphan reimbursement pathways could offer fair and equitable access to new antibioticsJennifer Quinn, Jutta Amersdorffer, Meindert Boysen, et al.
The Lancet. Haematology|July 18, 2017
Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled studyWojciech Jurczak, Ilídia Moreira, Govind Babu Kanakasetty, et al.
Pageof 1